Triple-agonist research peptide
Retatrutide 20mg
3mL vial
$120AUD
Research use only · Australia-wide dispatch
About this compound
Retatrutide is a synthetic peptide studied in laboratory models as a triple receptor agonist (GLP-1, GIP and glucagon). Supplied as a lyophilised powder in a sealed glass vial for in-vitro reconstitution and analytical work only.
Research areas
- Metabolic signalling pathway studies
- Receptor binding and agonist assays
- Comparative in-vitro peptide research
Specifications
- Compound
- Retatrutide
- Quantity
- 20mg lyophilised
- Purity
- ≥98% (HPLC)
- Form
- Sealed 3mL glass vial
- Storage
- Store 2-8°C, protect from light
Not for human consumption. This product is a laboratory research chemical. It is not a therapeutic good, is not TGA approved, and is not intended to diagnose, treat, cure or prevent any disease in humans or animals.
Sold only to qualified researchers aged 18 or over. The buyer accepts sole responsibility for lawful handling, storage and disposal under all applicable Australian laws.
